ReviewTopics in current chemistry (Cham)2026
MXene Nanomaterial Interfaces: Pioneering Neural Signal Recording for Brain-Computer Interfaces and Cognitive Therapy.
Review in Topics in current chemistry (Cham), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The development of cost-effective, high-accuracy MXene-based electrode devices is a promising approach for monitoring brain activity. The high conductivity and controllable surface chemistry make MXenes viable for neural stimulation and recording applications. In this review article of MXene integration into neural devices, we analyze the role of MXenes in advancing next-generation brain-computer interfaces (BCIs). High-resolution neural interfaces can be studied through cognitive rehabilitation investigations that examine real-time signal decoding capabilities and feedback systems in these devices. In addition to a summary of recent experimental findings from in vitro and in vivo models, the article also discusses engineering strategies for optimizing MXene-based systems for neural applications. The clinical implementation of future technologies must address challenges related to material stability and compatibility with biological tissues, as well as device miniaturization requirements. This investigation aims to evaluate MXenes as transformative materials that could drive breakthroughs in neural interface technology while advancing brain-machine interface functionality.
Indexed as
Identifiers
41940909What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.